A US medical resource group has recently accused Medtronic of using its size to shut down competition in the market for advanced bipolar devices.
California–based Applied Medical Rancho Santa Margarita filed an antitrust complaint yesterday in Central California’s US District Court.
“We are proud to be a leader in this competitive and growing space,” a Medtronic spokesperson said in a statement shared with MassDevice. “The claims are baseless and Medtronic will defend against the lawsuit filed by Applied Medical.”
Read more: Food Price Spikes Could Be Criminalized As FTC Called To Investigate Eggs
In a statement, Applied Medical said that it “hopes that this lawsuit will not only hold the defendant accountable for its actions but will also bring about lower prices and increased competition for advanced bipolar surgical devices, benefiting the public, patients, and healthcare overall.”
In its lawsuit, Applied Medical said Medtronic has a dominant 78% share of the advanced bipolar device market with its Ligasure device and it has dominance when it comes to a host of other surgical devices.
